Thompson Peter A.

Average Profitability
<0.0001%
Insider Buys Quantity
30
Insider Buys Sum
$132.85M
Insider Sells Quantity
15
Insider Sells Sum
$59.45M

Insider Activity of Thompson Peter A.

According to the SEC Form 4 filings, Thompson Peter A., being in a position of

  1. director at ARS Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 952377 shares for $12.59M,
    over all time since 2023-08-29, has bought 500000 shares for $3.1M, and sold 952377 shares for $12.59M.

The largest purchase of all time was on 2016-05-23 and amounted to 2383200 shares of Adaptimmune Therapeutics plc for $24.79M.

The largest sale of all time was on 2018-03-27 and amounted to 2032168 shares of Adaptimmune Therapeutics plc for $23.37M.

Biography of Thompson Peter A.

No biography is available at this moment.

2024-08-26SaleARS Pharmaceuticals, Inc.
SPRY
director
83,695
0.0772%
$13.00$1.09M+6.33%
2024-08-23SaleARS Pharmaceuticals, Inc.
SPRY
director
69,500
0.0642%
$13.03$905,585+8.18%
2024-08-22SaleARS Pharmaceuticals, Inc.
SPRY
director
391,482
0.3592%
$12.94$5.07M+9.41%
2024-08-21SaleARS Pharmaceuticals, Inc.
SPRY
director
407,700
0.3919%
$13.56$5.53M+4.55%
2024-01-23PurchaseEdgewise Therapeutics, Inc.
EWTX
454,545
0.5075%
$11.00$5M+15.6%
2023-08-29PurchaseARS Pharmaceuticals, Inc.
SPRY
director
500,000
0.2198%
$6.20$3.1M+14.03%
2022-09-16PurchaseEdgewise Therapeutics, Inc.
EWTX
484,496
1.0067%
$10.32$5M-6.89%
2022-05-18PurchaseEdgewise Therapeutics, Inc.
EWTX
276,000
0.5524%
$7.21$1.99M+30.03%
2021-12-29SaleJanux Therapeutics, Inc.
JANX
director
40,400
0.1004%
$20.30$820,120-30.21%
2021-12-21SaleJanux Therapeutics, Inc.
JANX
director
119,400
0.2901%
$19.00$2.27M-26.45%
2021-12-16SaleJanux Therapeutics, Inc.
JANX
director
393,300
0.9489%
$19.07$7.5M-26.9%
2021-09-20SaleCorvus Pharmaceuticals, Inc.
CRVS
1.11M
2.4922%
$6.09$6.76M-73.58%
2021-06-15PurchaseJanux Therapeutics, Inc.
JANX
director
705,853
6.4368%
$17.00$12M+1.61%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
718,750
0.7478%
$16.00$11.5M-42.5%
2021-02-17PurchaseCorvus Pharmaceuticals, Inc.
CRVS
1.29M
3.6216%
$3.50$4.5M-23.75%
2020-09-25PurchasePMV Pharmaceuticals, Inc.
PMVP
950,000
7.5696%
$18.00$17.1M-7.38%
2019-08-06PurchaseCorvus Pharmaceuticals, Inc.
CRVS
142,656
0.4786%
$3.51$500,723-1.4%
2019-07-01PurchaseCorvus Pharmaceuticals, Inc.
CRVS
59,243
0.1899%
$3.91$231,640-15.42%
2019-06-28PurchaseCorvus Pharmaceuticals, Inc.
CRVS
565,178
1.918%
$3.72$2.1M-5.88%
2019-06-27PurchaseCorvus Pharmaceuticals, Inc.
CRVS
32,923
0.1107%
$3.34$109,963+3.98%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.